Lycia Therapeutics, Inc. — Form D
Lycia Therapeutics, Inc. of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2026-06-25. The offering totals $75.0M, of which $75.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2026-06-25
- Form: D
- Accession: 0001806540-26-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $75.0M
- Amount sold: $75.0M
- Investors: 16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-588627
Issuer
- Name: Lycia Therapeutics, Inc.
- CIK: 0001806540
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 400 EAST JAMIE COURT, SUITE 200, SOUTH SAN FRANCISCO, CA, 94080
- Phone: (650) 392-3357
Officers, directors & promoters (21)
| Name | Role | Location |
|---|
| Tim Anderson | Related Person | South San Francisco, CA |
| Amy Bachrodt | Related Person | South San Francisco, CA |
| Ming Fang | Related Person | South San Francisco, CA |
| Laurent Fischer | Related Person | South San Francisco, CA |
| Clare Ozawa | Related Person | South San Francisco, CA |
| William Rieflin | Related Person | South San Francisco, CA |
| Aetna Wun Trombley | Related Person | South San Francisco, CA |
| Ming Fang | Director | South San Francisco, CA |
| Tim Anderson | Director | South San Francisco, CA |
| Clare Ozawa | Director | South San Francisco, CA |
| Laurent Fischer | Director | South San Francisco, CA |
| Andrew Gottesdiener | Director | South San Francisco, CA |
| William Rieflin | Director | South San Francisco, CA |
| Aetna Wun Trombley | Director | South San Francisco, CA |
| Aetna Wun Trombley | Executive Officer | South San Francisco, CA |
| Thomas Woiwode | Director | San Francisco, CA |
| Clare S Ozawa | Director | San Diego, CA |
| Thomas S Woiwode | Director | San Diego, CA |
| Laurent S Fischer | Director | San Diego, CA |
| Jeremy S Caldwell | Director | San Diego, CA |
| Jeremy S Caldwell | Executive Officer | San Diego, CA |
Other filings by this issuer (3)
More